Pfizer LimitedNSE: PFIZER

Press Release Dec 19 2025

· Issued by Pfizer Limited

Filed with NSE · · 4 pages · English

Summary by 6ix AI

Pfizer Limited has announced an exclusive supply and marketing agreement with Cipla Limited for several of its brands in India. The agreement covers the marketing and distribution of Corex Dx, Corex LS, Dolonex, and Neksium for an initial period of five years. This partnership aims to enhance the availability of these key brands across the country, leveraging Cipla's extensive distribution network. Pfizer will continue to manufacture and supply these medicines to Cipla under the terms of the agreement.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Pfizer Limited has informed the Exchange regarding a press release dated December 19, 2025, titled "Exclusive Supply and Marketing Agreement for Pfizer Limited s brands Corex Dx,Corex LS, Dolonex, and Neksium with Cipla Limited.".

Pfizer Limited on 6ix

Earlier from Pfizer

Later from Pfizer

All Pfizer news releases